Early lung cancer detection, mucosal, and alveolar imaging
Authors:
- Shaheen IslamSIShaheen Islam
- 1 May 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 22 (3) , 271-280
Abstract
Lung cancer is the leading cause of cancer deaths worldwide. Early detection is essential for long-term survival. Screening of high-risk individuals with low-dose computed tomography screening has proven to increase survival. However, current radiological imaging techniques have poor specificity for lung cancer detection and poor sensitivity for detection of mucosal or alveolar preinvasive malignant lesions. Bronchoscopy allows imaging and sampling of early lung cancer, with the highest safety profile and high diagnostic accuracy. Available technologies, such as autofluorescence bronchoscopy, narrow band imaging, and radial ultrasound bronchoscopy can significantly increase the yield and diagnostic accuracy of bronchoscopy for early cancer detection in the central airways. Newer technologies such as optical coherence tomography, confocal bronchoscopy, and Raman spectroscopy may significantly increase the diagnostic yield of both central and parenchymal early cancer lesions. Although some of these technologies are still investigational and are not readily available in most centers, they may identify early mucosal and alveolar cancer lesions accurately in the least invasive manner to provide appropriate therapy and prolong patient survival from lung cancer.Keywords
This publication has 38 references indexed in Scilit:
- Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted TherapyMedicine, 2015
- High definition bronchoscopy: a randomized exploratory study of diagnostic value compared to standard white light bronchoscopy and autofluorescence bronchoscopyRespiratory Research, 2015
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)The Lancet, 2015
- Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009Lung Cancer, 2014
- Survival After Community Diagnosis of Early-stage Non-small Cell Lung CancerThe American Journal of Medicine, 2014
- Advanced Imaging (Positron Emission Tomography and Magnetic Resonance Imaging) and Image-Guided Biopsy in Initial Staging and Monitoring of Therapy of Lung CancerThe Cancer Journal, 2013
- [18F]Fluorodeoxyglucose-positron emission tomography screening for lung cancer: a systematic review and meta-analysisCancer Imaging, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Virtual and fiber-optic bronchoscopy in patients with indication for tracheobronchial evaluationAnnals of Thoracic Medicine, 2010
- State of the ArtChest, 2007